Paul V. B.
- Country
- The Netherlands
- Department
- Cardiology
Research Overview
- Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Heterozygous Familial Hypercholesterolemia
- Evaluation of Evolocumab on Cardiovascular Outcomes in High-Risk Patients Without Prior Myocardial Infarction or Stroke
Data & Insights
Has run more than one trial at 351 of 980 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in treating acute myocardial infarction (AMI), with particular focus on emergency interventions and preventive strategies for patients at risk of recurrent cardiac events.
- Acute Cardiac Care
- Emergency Cardiovascular Medicine
- Preventive Cardiology
Research activities concentrate on innovative approaches for immediate response to cardiac emergencies.
Lipid Management
The investigator focuses on treating patients with Heterozygous Familial Hypercholesterolemia (HeFH) and disorders related to elevated low-density lipoprotein cholesterol levels.
- Lipid Disorders
- Cholesterol Management
- Familial Hypercholesterolemia
Clinical interests include developing therapeutic approaches for complex lipid disorders.
Preventive Medicine
The investigator works on therapeutic strategies for managing cardiovascular risk factors and implementing preventive measures for high-risk cardiac patients.
- Risk Factor Management
- Preventive Therapeutics
- Long-term Patient Care
Activities focus on developing comprehensive treatment approaches for at-risk populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.